Decreased signs of inflammation and no erosive progression on ultrasonography at 6 and 12 months in patients with rheumatoid arthritis in adalimumab and methotrexate combination therapy.
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Tidsskrift | Annals of the Rheumatic Diseases |
Vol/bind | 69 |
Udgave nummer | 3 |
Sider (fra-til) | 457 |
Antal sider | 1 |
ISSN | 0003-4967 |
Status | Udgivet - 2010 |
ID: 34063599